Abstract
Cytochrome P450 (CYPs) constitutes the major enzyme family capable of catalysing the oxidative biotransformation of most drugs. These are affected by a large number of factors including environmental elements. Widely practiced drinking of camel milk as a nutrient, therapy for some disease or even adjuvant with some drugs make it mandatory to investigate the possible CYPs modulator effects of camel milk. Forty-eight male Wistar rats were divided into 6 groups of 8 rats each. Groups were allocated as control, Camel milk (CM) treated, Sudan III (S.III) treated, S.III +CM, Phenobarbital (PB) or PB+CM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
